New initiatives for the control of Japanese encephalitis by vaccination: Minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998

Vaccine

Volumn 18, Issue SUPPL. 2, 2000, Pages 1-25

  Tsai, Theodore F ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE;

ASIA; CONFERENCE PAPER; COST; EPIDEMIC ENCEPHALITIS; HUMAN; JAPANESE ENCEPHALITIS VIRUS; PRIORITY JOURNAL; SYMPOSIUM; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 0034724144     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00037-2     Document Type: Conference Paper

References (75)

1. Xu Y.H., Zhaori G.T., Vene S., et al. Viral etiology of acute childhood encephalitis in Beijing diagnosed by analysis of single samples. Pediatr. Infect. Dis. J. 15:1996;1018-1024.
2. Liu Z.L., Hennessy S., Strom B.L., Tsai T.F., et al. Short-term safety of live-attenuated Japanese encephalitis vaccine (SA14-14-2): Results of a 26,239-subject randomized trial. J. Infect. Dis. 176:1997;1366-1369.
3. Kari K. personal communication.
4. Cardosa M.J., Hooi T.P., Kaur P. Japanese encephalitis virus is an important cause of encephalitis among children in Penang. Southeast Asia J. Trop. Med. Publ. Health. 26:1995;272-275.
5. Kumar R., Mathur A., Kumar A., Sharma S., Chakraborty S., Chaturvedi U.C. Clinical features and prognostic indicators of Japanese encephalitis in children in Lucknow (India). Indian J. Med. Res. 91:1990;321-327.
6. Joshi D.D. Japanese encephalitis in Nepal. Southeast Asian J. Trop. Med. Publ. Health. 26:1995;34-40.
7. Hanna J.N., Ritchie S.A., Phillips D.A., et al. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med. J. Aust. 165:1996;256-260.
8. Berg S.W., Mitchell B.S., Hanson R.K., et al. Systemic reactions in US Marine Corps personnel who received Japanese encephalitis vaccine. J. Infect. Dis. 24:1997;265-266.
9. Paul W.S., Moore P.S., Karabatsos N., Flood S.P., Yamada S., Jackson T., Tsai T.F. Outbreak of Japanese encephalitis on the island of Saipan, 1990. J. Infect. Dis. 167:1993;1053-1058.
10. Hoke C.H., Nisalak A., Sangawhipa N., et al. Protection against Japanese encephalitis by inactivated vaccines. N. Engl. J. Med. 319:1989;609-614.
11. Benenson M.W., Top F.H., Gresso W., Ames C.E., Alstatt L.B. The virulence of Japanese B encephalitis virus in Thailand. Am. J. Trop. Med. Hyg. 24:1975;974-980.
12. Grossman R.A., Edelman R., Willhight M., Pantuwatana S., Udomsakdis. Study of Japanese encephalitis virus in Chiang Mai Valley, Thailand. Am. J. Epidemiol. 98:1973;133-149.
13. Chow L.P., Wei H.Y., Chen C.L., Hsu S.T., Huang C.T., Kitaoka M., Sunaga H. A controlled field trial for an evaluation of effectiveness of mouse-brain Japanese encephalitis vaccine. J. Formosa Med. Assoc. 70:1971;55-61.
14. Okuno T., Tseng P.T., Hsu S.T., Huang C.T., Kuo C.C., Lin S.Y. Japanese encephalitis surveillance in China (Province of Taiwan) during 1958,1971. II. Age-specific incidence in connection with Japanese encephalitis vaccination program. Jpn. J. Med. Sci. Biol. 28:1975;255-267.
15. Hsu T.C., Chow L.P., Wei H.Y., et al. A completed field trial for an evaluation of the effectiveness of mouse-brain Japanese vaccine. McDhammon W., Kitaoka M., Downs W.G. Immunization for Japanese Encephalitis. 1972;285-291 Excerpta Medica, Amsterdam.
16. Tsai T.F., Chang J., Yu Y.X. Japanese encephalitis vaccines. Plotkin S.A., Orenstein W.A. Vaccines. 3rd ed. 1999;672-710 Saunders, Philadelphia, PA.
17. Hoke C.H., Vaughn D.W., Nisalak A., Intralawan P., Poolsuppasit S., Jongsawas V., Titsyakorn U., Johnson R.T. Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J. Infect. Dis. 165:1992;631-637.
18. Huang P.J., Huang Y.H., Wu P.H., Wu Y.C., Chen K.T. A survey of clinical sequelae of Japanese encephalitis. Epidemiol. Bull. 12:1996;19-26.
19. Huy B.V., Tu H.C., Luan T.V., Lindqvist R. Early mental and neurological sequelae after Japanese B encephalitis. Southeast Asian J. Trop. Med. Publ. Health. 25:1994;549-553.
20. Kumar R., Mathur A., Singh K.B., et al. Clinical sequelae of Japanese encephalitis in children. Indian J. Med. Res. [A]. 97:1993;9-13.
21. Kumar R., Mathur A., Kumar A., Sharma S., Chakraborty S., Chaturvedi U.C. Clinical features and prognostic indicators of Japanese encephalitis in children in Lucknow (India). Indian J. Med. Res. 91:1990;321-327.
22. Schneider R.J., Firestone M.H., Edelman R., Chieowanich P., Pornpibul R. Clinical sequelae after Japanese encephalitis: a one year follow-up study in Thailand. Southeast Asian J. Trop. Med. Publ. Health. 5:1974;560-568.
23. Pieper S.J.L., Kurland L.T. Sequelae of Japanese B and mumps encephalitis. Recent follow-up of patients affected in 1947-1948 epidemic on Guam. Am. J. Trop. Med. Hyg. 7:1958;481-490.
24. Simpson T.W., Meiklejohn G. Sequelae of Japanese B encephalitis. Am. J. Trop. Med. 27:1947;727-731.
25. Edelman R., Schneider R.J., Chieowanich P., Pornpibul R., Voodhikul P. The effect of dengue virus infection on the clinical sequelae of Japanese encephalitis: a one year follow-up study in Thailand. Southeast Asian J. Trop. Med. Publ. Health. 6:1975;308-315.
26. Kumar R., Selvan A.S., Sharma S., et al. Clinical predictors of Japanese encephalitis. Neuroepidemiology. 13:1994;97-102.
27. Burke D.S., Lorsomrudee W., Leake C.J., et al. Fatal outcome in Japanese encephalitis. Am. J. Trop. Med. Hyg. 34:1985;1203-1210.
28. Burke D.S., Morrill J.C. Levels of interferon in the plasma and cerebrospinal fluid of patients with acute Japanese encephalitis. J. Infect. Dis. 155:1987;797-799.
29. Kalayanarooj S. Japanese encephalitis: clinical manifestations, outcome and management. Southeast Asian J. Trop. Med. Publ. Health. 26:1995;9-10.
30. Tsai T.F. Flaviviruses. Mandell G.L., Bennett J.E., Dolin R. Principles and Practice of Infectious Diseases. 5th ed. 2000;1714-1736 Churchill Livingstone, Philadelphia, PA.
31. Levine O., Schwartz B. The rationale for population-based surveillance for Haemophilus influenzae type b meningitis. Pediatr. Infect. Dis. J. Sep:(179 Suppl):1998;S195-S198.
32. Siraprapasiri T., Sawaddiwudhipong W., Rojanasuphot S. Cost benefit analysis of Japanese encephalitis vaccination program in Thailand. Southeast Asia J. Trop. Med. Publ. Health. 28:1997;143-148.
33. Takahashi K., Matsuo R., Kuma M., et al. Use of vaccine in pigs. A. Effect of immunization of swine upon the ecological cycle of Japanese encephalitis virus. Hammon McD, Kitaoka M., Downs W.G. Immunization for Japanese encephalitis. 1972;292-303 Excerpta Medica, Amsterdam.
34. Vaughn D.W., Hoke C.H. The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol. Rev. 14:1992;197-221.
35. Goh K.T. Vaccines for Japanese encephalitis. Lancet. 348:1996;340.
36. Anonymous. Japanese encephalitis vaccine. Oya A. The National Institute of Health. Vaccine Handbook. 1st ed. 1996;104-113 Maruzen, Tokyo, Japan.
37. Supamit C., Warachit P. Japanese encephalitis in Thailand. Southeast Asian J. Trop. Med. Publ. Health. 26:1995;43-46.
38. Lowry PW, Truong DH, Hinh LD. Japanese encephalitis among hospitalized pediatric and adult patients with acute encephalitis syndrome in Hanoi, Vietnam, 1995.
39. Tam N.H., Yen N.T. Japanese encephalitis in Vietnam 1985-93. Southeast Asian J. Trop. Med. Publ. Health. 26:1995;47-50.
40. Hanna J., Barnett D., Ewald D. Vaccination against Japanese encephalitis in the Torres Strait. Communicable Dis. Intelligence. 20:1996;188-190.
41. Hanna J.N., Ritchie S.A., Phillips D.A., et al. Japanese encephalitis in north Queensland, Australia, 1998. Med. J. Australia. 170:1999;533-536.
42. Vitarana T. Japanese encephalitis in Sri Lanka. Southeast Asian J. Trop. Med. Publ. Health. 26:1995;41-42.
43. Gambel J.M., DeFraites R., Hoke C., et al. Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series. J. Infect. Dis. 171:1995;1074.
44. Konishi E., Kurane I., Mason P.W., et al. Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes. Am. J. Trop. Med. Hyg. 53:1995;278-283.
45. Chen W.-R., Rico-Hesse R., Tesh R.B. A new genotype of Japanese encephalitis virus from Indonesia. Am. J. Trop. Med. Hygiene. 47:1992;61-69.
46. Huong V.T., Ha Q.D.Q., Deubel V. Genetic study of Japanese encephalitis viruses from Vietnam. Am. J. Trop. Med. Hygiene. 49:1993;538-544.
47. Paranjpe S., Banerjee K. Phylogenetic analysis of the envelope gene of Japanese encephalitis virus. Virus Res. 41:1996;107-117.
48. Ma S.P., Arakaki S., Makino Y., Fukunaga T. Molecular epidemiology of Japanese encephalitis virus in Okinawa. Microbiol. Immunol. 40:1996;847-855.
49. Ritchie S.A., Phillips D., Broom A., Mackenzie J., Poidinger M., van den Hurk A. Isolation of Japanese encephalitis virus from Culex annulirostris in Australia. Am. J. Trop. Med. Hygiene. 56:1997;80-84.
50. Tsuchie H., Oda K., Vythilingam I., et al. Genotypes of Japanaese encephalitis virus isolated in three states in Malaysia. Am. J. Trop. Med. Hygiene. 56:1997;153-158.
51. Chung Y.J., Nam J.H., Ban S.J., Cho H.W. Antigenic and genetic analysis of Japanese encephalitis viruses isolated from Korea. Am. J. Trop. Med. Hygiene. 55:1996;91-97.
52. Ali A., Igarashi A. Antigenic and genetic variations among Japanese encephalitis virus strains belonging to genotype 1. Microbiol. Immunol. 41:1997;241-252.
53. Andersen M.M., Ronne T. Side effects with Japanese encephalitis vaccine. Lancet. 337:1991;1044.
54. Plesner A.M., Ronne T. Allergic mucocutaneous reactions to Japanese encephalitis vaccine. Vaccine. 15:1997;1239-1243.
55. Ruff T.A., Eisen D., fuller A., Kass R. Adverse reactons to Japanese encephalitis vaccine. Lancet. 338:1991;881-882.
56. Tsai T.F. Inactivated Japanese encephalitis virus vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 42 RR-1:1993;1-15.
57. Nothdurft H.D., Jelinek T., Marschang A., Maiwald H., Kapaun A., Loscher. Adverse reactions to Japanese encephalitis in travellers. J. Infection. 32:1996;119-122.
58. Nazareth B., Levin J., Johnson H., Begg N. Systemic allergic reactions to Japanese encephalitis vaccines. Vaccine. 12:1994;666.
59. Sakaguchi M., Yoshida M., Kuroda W., Haraya O., Matsunaga Y., Inouye S. Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines. Vaccine. 15:1997;121-122.
60. Plesner A.M., Soborg P.A., Herning M. Neurological complications and Japanese encephalitis vaccination. Lancet. 348:1996;202-203.
61. Shiraki H. Etiological study of demyelinating disease. Proc. Comm. Japanese Encephalitis Vaccine. 1:(70):1966;71.
62. Ohtaki E., Murakami Y., Komori H., Yamashita Y., Matsuishi T. Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination. Pedatr. Neurology. 8:1992;137-139.
63. Ohtaki E., Matsuishi T., Hirano Y., Maekawa K. Acute disseminated encephalomyelitis after treatment with Japanese B enceaphalitis vaccine (Nakayama-Yoken and Beijing strains). J. Neurology Neurosurg. Psychiatr. 59:1995;316-317.
64. Okinaka S., Toyokura Y., Tsukagoshi H., et al. Physical reactions following vaccination against Japanese B encephalitis with special reference to neurological complications. Adv. Neurol. Sci. 11:1965;410-424.
65. Chen B.Q., Beaty B.J. Japanese encephalitis vaccine (2-8 strain) and parent (SA 14 strain) viruses in Culex tritaeniorhynchus mosquitoes. Am. J. Trop. Med. Hygiene. 31:1982;403-407.
66. Ma X., Yu Y.X., Wang S.G. Observations on safety and serological efficacy from a large-scale field trial of Japanese encephalitis vaccine. Chinese J. Biologicals. 6:1993;188-191.
67. Tsai T.F., Yu Y.X., Jia L.L., et al. Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine - a comparison of 1- and 3-month immunizaton schedules. J. Infect. Dis. 177:1998;221-223.
68. Sohn Y.M., Park M.S., Rho H.O., Chandler L.J., Shope R.E., Tsai T.F. Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants. Vaccine. May 4;17:1999;2259-2264.
69. Hennessy S., Zhengle L., Tsai T.F., et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2) :a case-control study. Lancet. 347:1996;1583-1586.
70. WHO Expert Committee on Biological Standardization. Document in preparation.
71. Chambers T.J., Tsai T.F., Pervivkov Y., Monath T.P. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting. Vaccine. 15:1997;1494-1502.
72. Chambers T.J., Nestorowicz, Mason P.W., Rice C.M. Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. J. Virol. 73:1999;3095-3101.
73. Rojanasuphot S., Na-chiangmai P., Srijaggrawalong A., Nimmannitya S. Implementation of simultaneous Japanese encephalitis vaccine in the Expanded Program of Immunization of infants. Mosq. Borne Dis. Bull. 9:1992;86-92.
74. Intralawan P., Puapanwatana S., Hansuttivejakul R., Ratanisirisub P. Integration of Japanese encephalitis vaccine in EPI. Thai. J. Pediatr. 30:1991;5-10.
75. Rojanasuphot S., Shaffer N., Chotpitayasunondh T., et al. Response to JE vaccine among HIV-infected children, Bangkok, Thailand. Southeast Asian J. Trop. Med. Publ. Health. 29:1998;443-450.